Methinks thou doth protest too much7 May 2020 10:17
The fact that CPI have sold shares does not tell us anything about the company prospects. They will not have privileged information. They will be having to sell on occasions to fund other fledgling companies, which is CPI’s real purpose.
Yes, we would all like to have had the big announcement by now and there must be a certain amount of frustration with even the most hardened LTH, but no-news almost certainly means that things are going on behind the scenes, probably delayed by covid-19 events.
I was not a fan of the interviews given by Dan, especially with that spiv Justin Waite on VOX, and I am pretty sure that Keegan, the new addition to the bod, thought it best to stop them as it could affect potential discussions with Asian and particularly Japanese companies who are known to like to do things quietly and in their own particular methodical way.
Had discussions stopped and the deal dead then that would definitely require an immediate RNS
Investors are getting a little frustrated, especially those that bought-in around Xmas and thought they would see a quick multi-bag in Q1 but are now under water.
My personal belief is that nx002 is a drug with great potential, it is certainly shown to be much better than current drugs, and I believe may well help those with lung damage post covid19 and I think could even turn out to be a useful adjunct drug during primary treatment.
I will be holding on for the hoped for good news and the rewards that go with it. I think the news when it does start to come will be multiple news over a short period of time.
There are a couple of posters on here for whom the phrase ‘ Methinks thou doth protest too much’ should be their motto.
Well that is my post for the month over with.
GLA
Sign In
Follow the stocks
